000025651 000__ 01483cam\a2200361\i\4500
000025651 001__ 25651
000025651 003__ SzGeWIPO
000025651 005__ 20240708162147.0
000025651 008__ 080306s2009    xx |||||r|||| 00| 0 eng d
000025651 035__ $$a(wipo)0
000025651 035__ $$a(OCoLC)1161304947
000025651 040__ $$aSzGeWIPO $$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000025651 050_4 $$aK9$$b.N6
000025651 08204 $$a341.75805$$221
000025651 084__ $$a138$$qGB
000025651 1001_ $$aAdams, S.-j.,$$eauthor.
000025651 24510 $$aPharma falsehoods :$$bProprietary pharmaceutical companies are frequently lambasted for putting patents and profits above patients. GSK and others are now looking to set the record straight /$$cS.-J. Adams.
000025651 264_1 $$a[Place of publication not identified] :$$b[European Patent Office],$$c2009.
000025651 300__ $$a1 volume ([7] pages) ;$$c[28] cm.
000025651 336__ $$atext$$btxt$$2rdacontent
000025651 337__ $$aunmediated$$bn$$2rdamedia
000025651 338__ $$avolume$$bnc$$2rdacarrier
000025651 4901_ $$aIntellectual Asset Management Magazine (IAM),$$x1741-1424 ;$$vGB 138 Jul/Aug 2009 No 37, pages 61-67
000025651 650_0 $$aIntellectual property.
000025651 650_0 $$aPatents.
000025651 650_4 $$aPharmaceutical industry
000025651 650_4 $$aPharmaceutical patents
000025651 7102_ $$aEuropean Patent Office.
000025651 830_0 $$aIntellectual Asset Management Magazine (IAM) ;$$vGB 138 Jul/Aug 2009 No 37, pages 61-67.
000025651 903__ $$aIntellectual Asset Management Magazine (IAM).
000025651 904__ $$aJournal article
000025651 942__ $$cART$$jGB 138  Jul/Aug 2009 No 37$$2ddc
000025651 952__ $$w2010-01-26$$p2010-0183$$u39677$$bMAIN$$10$$kGB 138 $$v2010-01-26$$70$$cMain Library$$yART
000025651 980__ $$aBIB
000025651 999__ $$c28015$$d28015